Refine
Document Type
- Article (4)
Has Fulltext
- yes (4)
Is part of the Bibliography
- no (4)
Keywords
- COVID-19 (1)
- Hematopoietic stem cell transplant (1)
- Long-term follow-up (1)
- NMR spectroscopy (1)
- SARS-CoV-2 (1)
- Sequelae (1)
- TBI (1)
- Toxicity (1)
- accessory proteins (1)
- cell-free protein synthesis (1)
Institute
- Geographie (2)
- Biochemie, Chemie und Pharmazie (1)
- Medizin (1)
Feministische Geographien und geographische Geschlechterforschung umfassen eine Vielzahl an Themenfeldern und Fragestellungen zum Zusammenhang von Raum und Geschlecht(lichkeit), die aus unterschiedlichen theoretischen Perspektiven in allen geographischen Bereichen behandelt werden können. In unserem Beitrag liefern wir einen Überblick über Inhalte, Ziele und Entwicklungspfade von Geschlechter- und feministischer Forschung in der deutschsprachigen Geographie. Dieser Überblick ist in allgemeine Überlegungen zu Geschlechterforschung in den Sozialwissenschaften eingebettet und an verschiedenen geschlechtertheoretischen Perspektiven – Frauen-, Geschlechterverhältnis-, Männer-/Männlichkeits- und Geschlechtsforschung – orientiert. Entlang der Frage "Wie weiblich ist die Nacht?" werden die Ausführungen zu den Fragestellungen, Blickachsen und Arbeitsweisen feministischer Geographien an zwei Beispielen konkretisiert und vertieft.
Menschliche Körper und Räume sind wechselseitig aufeinander bezogen und sehr ähnlichen gesellschaftlichen Konstitutionsbedingungen unterworfen. Dessen ungeachtet wurde der Körper mit seinen Bedeutungen für die Konstruktion und Aneignung von Räumen in der Geographie bisher kaum thematisiert. Dieser Beitrag widmet sich aus feministisch-poststrukturalistischer Perspektive dem dynamischen Wechselverhältnis von Körpern und Räumen. Besonders hervorgehoben werden dabei die Bedeutungen von Fremd- und Eigenwahrnehmung für vielfältige Raumaneignungsstrategien. Damit wird zugleich ein theoretischer Ansatz zur Diskussion gestellt, der neue Betrachtungs- und Analyseebenen eröffnet.
Purpose: Total body irradiation (TBI) is a common part of the myelo- and immuno-ablative conditioning regimen prior to an allogeneic hematopoietic stem cell transplantation (allo-HSCT). Due to concerns regarding acute and long-term complications, there is currently a decline in otherwise successfully established TBI-based conditioning regimens. Here we present an analysis of patient and treatment data with focus on survival and long-term toxicity.
Methods: Patients with hematologic diseases who received TBI as part of their conditioning regimen prior to allo-HSCT at Frankfurt University Hospital between 1997 and 2015 were identified and retrospectively analyzed.
Results: In all, 285 patients with a median age of 45 years were identified. Median radiotherapy dose applied was 10.5 Gy. Overall survival at 1, 2, 5, and 10 years was 72.6, 64.6, 54.4, and 51.6%, respectively. Median follow-up of patients alive was 102 months. The cumulative incidence of secondary malignancies was 12.3% (n = 35), with hematologic malignancies and skin cancer predominating. A TBI dose ≥ 8 Gy resulted in significantly improved event-free (p = 0.030) and overall survival (p = 0.025), whereas a total dose ≤ 8 Gy and acute myeloid leukemia (AML) diagnosis were associated with significantly increased rates of secondary malignancies (p = 0.003, p = 0.048) in univariate analysis. No significant correlation was observed between impaired renal or pulmonary function and TBI dose.
Conclusion: TBI remains an effective and well-established treatment, associated with distinct late-toxicity. However, in the present study we cannot confirm a dose–response relationship in intermediate dose ranges. Survival, occurrence of secondary malignancies, and late toxicities appear to be subject to substantial confounding in this context.
The highly infectious disease COVID-19 caused by the Betacoronavirus SARS-CoV-2 poses a severe threat to humanity and demands the redirection of scientific efforts and criteria to organized research projects. The international COVID19-NMR consortium seeks to provide such new approaches by gathering scientific expertise worldwide. In particular, making available viral proteins and RNAs will pave the way to understanding the SARS-CoV-2 molecular components in detail. The research in COVID19-NMR and the resources provided through the consortium are fully disclosed to accelerate access and exploitation. NMR investigations of the viral molecular components are designated to provide the essential basis for further work, including macromolecular interaction studies and high-throughput drug screening. Here, we present the extensive catalog of a holistic SARS-CoV-2 protein preparation approach based on the consortium’s collective efforts. We provide protocols for the large-scale production of more than 80% of all SARS-CoV-2 proteins or essential parts of them. Several of the proteins were produced in more than one laboratory, demonstrating the high interoperability between NMR groups worldwide. For the majority of proteins, we can produce isotope-labeled samples of HSQC-grade. Together with several NMR chemical shift assignments made publicly available on covid19-nmr.com, we here provide highly valuable resources for the production of SARS-CoV-2 proteins in isotope-labeled form.
